Diabetic nephropathy

Clinics in Laboratory Medicine

Volumn 21, Issue 1, 2001, Pages 111-146

  McGowan, T ^a   McCue, P ^a   Sharma, K ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; UNITED STATES;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY GLOMERULUS;

EID: 0035074891     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Diabetic glomerulopathy: Histopathologic, immunofluorescent, and ultrastructural studies of 16 cases
2. The predictive value of microalbuminuria in IDDM: A five-year follow-up study
3. Short and long term effects of antihypertensive therapy in the diabetic rat
4. Clinical practice recommendations: Diabetic nephropathy
5. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells
6. 2+ mobilization
7. More glomerular changes in diabetics
8. Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM
9. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
10. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes
11. A re-evaluation of diabetic glomerulosclerosis 50 years after the discovery of insulin
12. Declining incidence of nephropathy in insulin-dependent diabetes mellitus
13. Transforming growth factor beta in tissue fibrosis
14. The excessive incidence of diabetic end-stage renal disease among blacks: A population-based study of potential explanatory factors
15. Losartan decreases plasma levels of TGF-beta 1 in transplant patients with chronic allograft nephropathy
16. The interaction of hypertension and diabetes on renal function in black NIDDM subjects
17. Abysmal prognosis of patients with type 2 diabetes entering dialysis
18. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes
19. Diabetic nephropathy
20. Plasma prorenin activity as an early marker of nephropathy in diabetic (IDDM) adolescents
21. Immunhistochemical studies in diabetic glomerulosclerosis
22. Albuminuria reflects widespread vascular damage: The Steno hypothesis
23. Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic nephropathy
24. Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease
25. Necrosis of renal papillae and acute pyelonephritis in diabetes mellitus
26. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients
27. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats
28. Circulating endothelin-1 levels in lean noninsulin-dependent diabetic patients: Influence of ACE inhibitors
29. Ultrastructural renal changes in juvenile diabetes
30. Elution studies in kidneys with linear deposition of immunoglobulins in glomeruli
31. Heterogeneous nature of renal lesions in type II diabetes
32. Diabetic nephropathy: A clinical and pathologic study based on renal biopsies
33. Use of single voided urine samples to estimate quantitative proteinuria
34. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats
35. Renal papillary necrosis: A sixteen-year clinical experience
36. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
37. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
38. TGF β1 stimulates rat mesangial cell proliferation in culture: Role of PDGF β receptor expression
39. Renal hemodynamics and segmental tubular resorption in early type 1 diabetes
40. Similar risks of nephropathy in patients with type I or type II diabetes mellitus
41. Transcriptional activation of TGF-b1 by high glucose
42. Glomerular hemodynamics in experimental diabetes mellitus
43. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation
44. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores
45. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
46. Renal disease and hypertension in non-insulin dependent diabetes mellitus
47. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus
48. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relation with diabetic nephropathy
49. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium
50. Studies on renal biopsy specimens with the aid of the electron microscope. I. Glomeruli in diabetes
51. Intercapillary lesions in glomeruli of kidney
52. Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota
53. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats
54. Genetics of diabetic nephropathy: Evidence for major and minor gene effects
55. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy
56. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance
57. Renal interstitial expansion in insulin-dependent diabetes mellitus
58. The exudative lesion in diabetic glomerulosclerosis
59. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
60. Prevalence of raised sodium-lithium countertransport activity in type 1 diabetic patients
61. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
62. Microalbuminuria as a predictor of diabetic nephropathy
63. Prediction of clinical diabetic nephropathy in IDDDM patients: Alternatives to microalbuminuria?
64. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset
65. Intrarenal microaneurysms in diabetic nephropathy
66. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
67. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria
68. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians
69. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia damage
70. Renal hemodynamics in recent-onset type II diabetes
71. The renal hemodynamic basis of diabetic nephropathy
72. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats
73. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension
74. Epidemiology of renal involvement in newly diagnosed middle-aged and elderly diabetic patients: Cross-sectional data from the population-based study "Diabetes Care in General Practice," Denmark
75. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II
76. Structural changes in the diabetic kidney
77. A quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro- and normoalbuminuria
78. Diabetic glomerulopathy: Structural characteristics of the early and advanced stages
79. Advanced diabetic glomerulopathy: Quantitative structural characterization of non-occluded glomeruli
80. Podocyte loss and progressive glomerular injury in type II diabetes
81. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes
82. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy
83. Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition
84. End-stage renal disease attributable to diabetes mellitus
85. Blood pressure control, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study
86. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus
87. Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells
88. Comparison of the course to end-stage renal disease of type-1 (insulin-dependent) and type-2 (non-insulin dependent) diabetic nephropathy
89. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy
90. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
91. Familial factors determine the development of diabetic nephropathy in patients with IDDM
92. Proteinuria, renal impairment, metabolic control, and blood pressure in type-2 diabetes-mellitus: A 14-year follow-up report on 195 patients
93. Understanding the nature of renal disease progression
94. Incidence and prevalence of ESRD
95. Nephropathy in patients with type 2 diabetes mellitus
96. Primary care: Nephropathy in patients with type 2 diabetes mellitus
97. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
98. Diabetic nephropathy in type II diabetes
99. TGF-β: Regulation of extracellular matrix
100. Increased glomerular filtration rate as a predictor of diabetic nephropathy: An 8-year prospective study
101. Mesangiolysis in diabetic glomeruli: Its role in the formation of nodular lesions
102. Smoking is associated with progression of diabetic nephropathy
103. Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment
104. Screening for microalbuminuria: A comparison of single sample methods of collection and techniques of albumin analysis
105. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes
106. Renal clinicopathology of type-II diabetes mellitus
107. Z-2 micosatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy
108. Captopril-induced reduction of serum levels of transforming growth factor-b1 correlates with long-term renoprotection in insulin-dependent diabetic patients
109. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
110. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy
111. The emerging role of transforming growth factor-β in kidney diseases
112. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator
113. Increased renal production of transforming growth factor-β 1 in patients with type II diabetes
114. Racial differences in the incidence and progression of renal diseases
115. Elevated plasma endothelin in patients with diabetes mellitus
116. Studies of diabetic glomerulosclerosis using an immunofluorescent technique
117. PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycation end products
118. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity
119. Genetic factors in the development of diabetic nephropathy
120. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
121. Glomerular membranopathy in adolescents with insulin-dependent diabetes
122. Immunohistopathology of diabetic glomerulosclerosis
123. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus
124. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy
125. The renal tubulointerstitium in diabetes mellitus
126. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β